Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2025-12-25 @ 2:29 AM
NCT ID:
NCT04641234
Eligibility Criteria:
Inclusion Criteria:
* Adult (≥18 years) patients diagnosed with nAMD
* Anti-VEGF treatment-naïve
* Started Intravitreal (IVT) aflibercept treatment between 01 January 2016 and 30 November 2018
* Aflibercept treatment according to Treat-and-Extend (T\&E) immediately after the loading dose
* Availability of medical records of aflibercept treatment.
Exclusion Criteria:
* Participation in an investigational program with interventions outside of routine clinical practice during the aflibercept treatment
* Patients with eye diseases that required surgery during the first 24 months of aflibercept treatment, e.g. advanced glaucoma, visually significant cataracts.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04641234
Study Brief:
Protocol Section:
NCT04641234